no abnormal phenotype detected_Irf2<tm1Mak>/Irf2<+>

http://metadb.riken.jp/0002169EI129S2SvPasC57BL6JorI129S2SvPasC57BL6JDBA2Irf2tm1MakIrf2Irf2tm1MakIrf2

no abnormal phenotype detected_Irf2<tm1Mak>/Irf2<+>

表現型アノテーション

MGI marker

http://metadb.riken.jp/db/mgi_rdf/variant_of

• interferon regulatory factor 2
  http://metadb.riken.jp/db/mgi_rdf/MGI:96591

遺伝子型

http://metadb.riken.jp/db/mgi_rdf/allele_composition

• Irf2<tm1Mak>/Irf2<+>

アレルシンボル

http://metadb.riken.jp/db/mgi_rdf/allele_symbol

• Irf2<tm1Mak>|Irf2<+>

遺伝的背景

http://metadb.riken.jp/db/mgi_rdf/genetic_background

• either: (involves: 129S2/SvPas * C57BL/6J) or (involves: 129S2/SvPas * C57BL/6J * DBA/2)

MP annotation

http://metadb.riken.jp/db/bioresource_schema/brs_indicatesPhenotype

• no abnormal phenotype detected
  http://purl.obolibrary.org/obo/MP_0002169

文献

http://purl.org/net/cito/citesAsAuthority

• T. Matsuyama, et.al., Targeted disruption of IRF-1 or IRF-2 results in abnormal type I IFN gene induction and aberrant lymphocyte development., Cell, 1993, 75
  http://rdf.ncbi.nlm.nih.gov/pubmed/8402903